Top Markets
Coin of the day
Tvardi Therapeutics, Inc. Tvardi Therapeutics, Inc.

Tvardi Therapeutics, Inc.

TVRD
Classement en actions #30251
Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages... Tvardi Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of novel, oral, and small molecule therapies targeting signal transducer and activator of transcription 3 (STAT3) to treat inflammatory and proliferative diseases with significant unmet need in the United States. The company's lead product candidates include TTI-101, which is in Phase 1b/2 clinical development stage for fibrosis-driven diseases with an initial focus on idiopathic pulmonary fibrosis (IPF), and hepatocellular carcinoma (HCC); and TTI-109, an oral, small molecule STAT3 inhibitor which is in Phase-1 clinical trial stage. Tvardi Therapeutics, Inc. was founded in 2017 and is based in Sugar Land, Texas.
Prix de l'action
$1.88
Dernière synchronisation: 2026-08-18
Capitalisation boursière
$17.59M
Changement (1 jour)
0.81%
Changement (1 an)
-92.40%
Pays
US
Échange Tvardi Therapeutics, Inc. (TVRD)

Catégorie

Historique des divisions d’actions pour Tvardi Therapeutics, Inc. (TVRD)
L’action Tvardi Therapeutics, Inc. (symbole : TVRD) a subi un total de 0 divisions.
La division la plus récente a eu lieu le Aug 19, 2026.
Une action TVRD achetée avant le Aug 19, 2026 équivaudrait aujourd’hui à 0 actions TVRD.
Liste des divisions d’actions
Année Division Multiplicateur Multiplicateur cumulatif
Pas assez de données pour les dates fournies.
Divisions d’actions d’entreprises similaires ou concurrentes
Entreprise Nombre de divisions d’actions Multiplicateur cumulatif Pays
1 x2
US
0 -
NL
1 x3
AU
0 -
CH
0 -
BE